Clinical Trial Update: Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral Deucrictibant XR Tablet for prophylaxis and Deucrictibant IR Capsule for on-demand treatment of angioedema in adults with Acquired…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Angioedema Due to C1-inhibitor Deficiency

Drugs mentioned

• Deucrictibant IR Capsule (Deucrictibant)
• Deucrictibant XR Tablet (Deucrictibant)

Snippet

Sponsor: Pharvaris Netherlands B.V. | Conditions: Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) | Phase 3 | Status: RECRUITING